NCT01070433View on ClinicalTrials.gov

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Diabetic Foot Ulcers
Interventions
DRUG

MEBO Wound Ointment (MEBO)

Topical application twice a day

OTHER

Standard of Care

Topical application twice a day

Trial Locations (9)

78229

Endeavor Clinical Trials, San Antonio Podiatry Associates, San Antonio

78501

Complete Family Foot Care, McAllen

85032

HOPE Research Institute, Phoenix

89119

Advanced Foot and Ankle Center, Las Vegas

90010

Foot and Ankle Clinic, Los Angeles

92024

ILD Consulting, Inc., Encinitas

93720

Valley Vascular Surgery Associates, Fresno

94546

Center for Clinical Research, Inc., Castro Valley

95628

Sacramento Foot and Ankle Center, Fair Oaks

All Listed Sponsors
lead

Skingenix, Inc.

INDUSTRY

NCT01070433 - A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter